Comprehensive background research efforts to identify detailed professional information pertaining to Evgeny Kontarzhy at Beckman Coulter Life Sciences yielded no publicly accessible data. Neither role, responsibilities, contact details, professional achievements, nor direct content linking this individual to Beckman Coulter Life Sciences are available through corporate web resources or associated service and product pages.
Contextual Company Profile - Beckman Coulter Life Sciences
Though individual-specific data is unavailable, the company context provides insights into operational focus and product domains relevant to the contact’s organizational environment:
- Beckman Coulter Life Sciences specializes in clinical diagnostics and laboratory instruments, offering solutions that encompass:
- _Automation Systems_
- _Blood Banking_
- _Chemistry Analyzers_
- _Clinical Information Management_
- _Hematology_
- _Immunoassay_
- _Microbiology_
- _Protein Chemistry_
- _Urinalysis_
- Recent product innovations include:
- DxC 500 AU Chemistry Analyzer
- DxI 9000 Access Immunoassay Analyzer
- The company highlights initiatives in high-impact medical research areas such as:
- Neurodegenerative disease assays (GFAP, NfL, APOE ε4, pTau-217)
- Antimicrobial resistance
- Diagnostic testing for infectious diseases
- Host response to infection and digital hematology
- Beckman Coulter actively supports clinical laboratories via professional education, technical documentation, support services, and software resources aimed at improving workflow efficiency, accuracy, and diagnostic decision-making.
Operational and Logistical Insights
- The company observes federal holidays such as Presidents' Day with office closures, emphasizing the need for advanced order placement to maintain supply chain continuity.
- Their global footprint includes professional use product availability regulated under the IVD Directive 98/79/EC.
- Beckman Coulter is part of Danaher Corporation, indicating strong corporate backing and service integration.
Due to the absence of contact-specific data, this report situates Evgeny Kontarzhy within the operational framework of Beckman Coulter Life Sciences and offers comprehensive context on company capabilities and priorities that define the professional environment in which the contact likely functions.
